NCT02798276 - Efficacy of the Adipose Graft Transposition Procedure (AGTP) in Patients With a Myocardial Scar: The AGTP II Trial | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 1, 2017

Primary Completion Date

October 31, 2025

Study Completion Date

November 30, 2025

Conditions

Myocardial Infarction

Interventions

PROCEDURE

AGTP-treatment

Patients with a myocardial necrosis candidates for revascularization of other myocardial areas, will be enrolled. The non-revascularizable area will be covered with the adipose graft and the revascularizable area will be treated with the normal procedure (by-pass).

OTHER

Control

Patients with a myocardial necrosis, candidates for revascularization of other myocardial areas, will be enrolled. The non-revascularizable area will be left untouched and the revascularizable area will be treated normally (by-pass).

Trial Locations (9)

28007

RECRUITING

Hospital General Universitario Gregorio Marañón, Madrid

28222

RECRUITING

Hospital Universitario Puerta de Hierro, Majadahonda

29010

NOT_YET_RECRUITING

Hospital Virgen de la Victoria, Málaga

30120

NOT_YET_RECRUITING

Hospital Clínico Universitario Virgen de la Arrixaca, Murcia

33011

RECRUITING

Hospital Universitario Central de Asturias, Oviedo

46010

RECRUITING

Hospital Clínico Universitario de Valencia, Valencia

47003

RECRUITING

Hospital Clínico Universitario de Valladolid, Valladolid

08916

RECRUITING

Germans Trias University Hospital; Germans Trias Research Institute, Badalona

Unknown

RECRUITING

Son Espases Hospital, Palma de Mallorca

All Listed Sponsors

lead

Antoni Bayés Genís

OTHER